Filing Details

Accession Number:
0001567619-19-012238
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-28 16:56:41
Reporting Period:
2019-05-28
Accepted Time:
2019-05-28 16:56:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1676725 Ideaya Biosciences Inc. IDYA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207114 M Timothy Shannon C/O Canaan Partners
285 Riverside Avenue, Suite 250
Westport CT 06880
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-28 1,658,164 $0.00 1,658,164 No 4 C Indirect See footnote
Common Stock Acquisiton 2019-05-28 602,549 $0.00 2,260,713 No 4 C Indirect See footnote
Common Stock Acquisiton 2019-05-28 400,000 $10.00 2,660,713 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-05-28 1,658,164 $0.00 1,658,164 $0.00
Common Stock Series B Preferred Stock Disposition 2019-05-28 602,549 $0.00 602,549 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
  2. Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
  3. The reported securities are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X", and together with the Canaan Fund, the "Canaan Entities"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X.
  4. Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.